Latest news
25 items- SECSEC Form 15-12G filed by Apexigen Inc.15-12G - Apexigen, Inc. (0001814140) (Filer)
- INSIDERSEC Form 4 filed by Zabrowksi Dan4 - Apexigen, Inc. (0001814140) (Issuer)
- INSIDERSEC Form 4: Wertheimer Samuel P returned 146,383 shares to the company, closing all direct ownership in the company4 - Apexigen, Inc. (0001814140) (Issuer)
- INSIDERSEC Form 4 filed by Smith Scott Andrew4 - Apexigen, Inc. (0001814140) (Issuer)
- INSIDERSEC Form 4: Ringold Gordon returned 10,000 shares to the company, closing all direct ownership in the company4 - Apexigen, Inc. (0001814140) (Issuer)
- INSIDERSEC Form 4 filed by Chhabra Meenu4 - Apexigen, Inc. (0001814140) (Issuer)
- INSIDERSEC Form 4 filed by Dupont Jakob4 - Apexigen, Inc. (0001814140) (Issuer)
- INSIDERSEC Form 4 filed by Cross Herb4 - Apexigen, Inc. (0001814140) (Issuer)
- INSIDERSEC Form 4: Wong Amy covered exercise/tax liability with 15,561 shares and returned 66,565 shares to the company, closing all direct ownership in the company4 - Apexigen, Inc. (0001814140) (Issuer)
- INSIDERSEC Form 4: Sarena Francis Willard covered exercise/tax liability with 31,123 shares and returned 124,296 shares to the company, closing all direct ownership in the company4 - Apexigen, Inc. (0001814140) (Issuer)
- INSIDERSEC Form 4: Hsu Frank J. returned 16,354 shares to the company, closing all direct ownership in the company4 - Apexigen, Inc. (0001814140) (Issuer)
- INSIDERSEC Form 4: Duke William E. covered exercise/tax liability with 26,416 shares and returned 128,001 shares to the company, closing all direct ownership in the company4 - Apexigen, Inc. (0001814140) (Issuer)
- INSIDERSEC Form 4: Yang Xiaodong was granted 400,000 shares, covered exercise/tax liability with 69,161 shares and returned 863,729 shares to the company, closing all direct ownership in the company4 - Apexigen, Inc. (0001814140) (Issuer)
- INSIDERSEC Form 3 filed by new insider Dupont Jakob (Amendment)3/A - Apexigen, Inc. (0001814140) (Issuer)
- SECSEC Form S-8 POS filed by Apexigen Inc.S-8 POS - Apexigen, Inc. (0001814140) (Filer)
- SECApexigen Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Apexigen, Inc. (0001814140) (Filer)
- SECSEC Form 25-NSE filed by Apexigen Inc.25-NSE - Apexigen, Inc. (0001814140) (Subject)
- SECApexigen Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Apexigen, Inc. (0001814140) (Filer)
- SECApexigen Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Apexigen, Inc. (0001814140) (Filer)
- SECSEC Form DEFA14A filed by Apexigen Inc.DEFA14A - Apexigen, Inc. (0001814140) (Filer)
- SECApexigen Inc. filed SEC Form 8-K: Other Events8-K - Apexigen, Inc. (0001814140) (Filer)
- SECSEC Form 425 filed by Apexigen Inc.425 - Apexigen, Inc. (0001814140) (Subject)
- SECSEC Form 425 filed by Apexigen Inc.425 - Apexigen, Inc. (0001814140) (Subject)
- SECSEC Form 10-Q filed by Apexigen Inc.10-Q - Apexigen, Inc. (0001814140) (Filer)
- SECSEC Form 425 filed by Apexigen Inc.425 - Apexigen, Inc. (0001814140) (Subject)
APGN FAQ
5 questionsWhere does APGN stock trade?
Apexigen Inc. (APGN) is listed on NASDAQ.What sector and industry is APGN in?
Apexigen Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Apexigen Inc. go public?
Apexigen Inc. (APGN) completed its IPO in 2021.What companies are similar to APGN?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare APGN side-by-side with any of them on Quantisnow.How can I track APGN on Quantisnow?
Quantisnow aggregates Apexigen Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow APGN to receive live email and push alerts on every new disclosure.